Search

everythinglearnresearchcommunity

for

Search:↓

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Dermoscopy helps diagnose rare GLPLS in males.

Abrocitinib may effectively treat Lichen Planopilaris.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

Lichen planopilaris can be triggered by prolonged scalp traction and can be treated with corticosteroids.

Scalp edema may be a new variant of conditions reacting to scarring alopecia like LPP.

Strict regulations may slow down new LLLT treatments.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Topical dapsone may effectively treat lichen planopilaris in the beard, especially for those who can't tolerate standard treatments.

Lichen planopilaris may have a genetic link.

Poly-D,L-lactic acid boosts hair growth in aged skin by activating hair follicle stem cells.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

Early detection of scalp signs can prevent permanent scarring in Lichen Planopilaris.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Accurate early diagnosis of Lichen Planopilaris is crucial to prevent permanent hair loss.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

p2y5, now called LPA6, is a receptor important for human hair growth.

Up to 10% of hair loss patients might have early signs of a condition called Lichen Planopilaris.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

Lichen Planus in siblings may be influenced by genetics and environment.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Trichoscopy helps distinguish between scalp Discoid Lupus Erythematosus and Lichen Planopilaris for accurate diagnosis and treatment.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

JAK inhibitors might help treat Lichen Planopilaris, but more research is needed.

FFA has higher long-term remission rates than LPP.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

DLP bioprinting shows promise for medical uses, but needs more material options and strength improvements.